Anupam B. Jena : Citation Profile


Are you Anupam B. Jena?

Harvard University

8

H index

7

i10 index

160

Citations

RESEARCH PRODUCTION:

10

Articles

10

Papers

1

Chapters

RESEARCH ACTIVITY:

   11 years (2005 - 2016). See details.
   Cites by year: 14
   Journals where Anupam B. Jena has often published
   Relations with other researchers
   Recent citing documents: 28.    Total self citations: 10 (5.88 %)

MORE DETAILS IN:
ABOUT THIS REPORT:

   Permalink: http://citec.repec.org/pje47
   Updated: 2020-02-22    RAS profile: 2012-11-30    
   Missing citations? Add them    Incorrect content? Let us know

Relations with other researchers


Works with:

Authors registered in RePEc who have co-authored more than one work in the last five years with Anupam B. Jena.

Is cited by:

Lechner, Michael (12)

Basu, Anirban (11)

Lakdawalla, Darius (10)

Goldman, Dana (8)

Towse, Adrian (6)

boone, jan (6)

Williams, Heidi (6)

Pertile, Paolo (5)

Miraldo, Marisa (5)

Murphy, Kevin (4)

Becker, Gary (4)

Cites to:

Philipson, Tomas (22)

Nordhaus, William (7)

Cutler, David (6)

Jones, Charles (5)

Shapiro, Jesse (5)

Romer, Paul (4)

Becker, Gary (4)

Newhouse, Joseph (4)

Acemoglu, Daron (4)

Linn, Joshua (4)

Johannesson, Magnus (4)

Main data


Where Anupam B. Jena has published?


Journals with more than one article published# docs
Journal of Health Economics4
Forum for Health Economics & Policy3

Recent works citing Anupam B. Jena (2019 and 2018)


YearTitle of citing document
2018The value of extending life at its end: Health care allocation in the presence of learning spillovers. (2018). Hintermann, Beat ; Minke, Matthias. In: Working papers. RePEc:bsl:wpaper:2018/15.

Full description at Econpapers || Download paper

2017The Unexpected Consequences of Asymmetric Competition. An Application to Big Pharma. (2017). Siotis, Georges ; Ornaghi, Carmine ; Castanheira, Micael ; de Frutos, Maria-Angeles . In: CEPR Discussion Papers. RePEc:cpr:ceprdp:11813.

Full description at Econpapers || Download paper

2018How does product liability risk affect innovation? Evidence from medical implants. (2018). Galasso, Alberto ; Luo, Hong. In: CEPR Discussion Papers. RePEc:cpr:ceprdp:13036.

Full description at Econpapers || Download paper

2019Do doctors improve the health care of their parents? Evidence from admission lotteries. (2019). Klaauw, Basvan Der ; Oosterbeek, Hessel ; Artmann, Elisabeth ; van der Klaauw, Bas. In: CEPR Discussion Papers. RePEc:cpr:ceprdp:14061.

Full description at Econpapers || Download paper

2017An Evaluation of the Proposed Worker Protection Standard with Respect to Pesticide Exposure, and Parkinson’s Disease. (2017). Martin, David ; Posey, Lillian B ; Sparling, Alica Stubnova . In: Working Papers. RePEc:dav:wpaper:17-02.

Full description at Econpapers || Download paper

2018A comparison of the robust conditional order-m estimation and two stage DEA in measuring healthcare efficiency among California counties. (2018). Gearhart, Richard S ; Michieka, Nyakundi M. In: Economic Modelling. RePEc:eee:ecmode:v:73:y:2018:i:c:p:395-406.

Full description at Econpapers || Download paper

2018Altruism in preventive health behavior: At-scale evidence from the HIV/AIDS pandemic. (2018). Wilson, Nicholas. In: Economics & Human Biology. RePEc:eee:ehbiol:v:30:y:2018:i:c:p:119-129.

Full description at Econpapers || Download paper

2018An exploratory case study of the impact of expanding cost-effectiveness analysis for second-line nivolumab for patients with squamous non-small cell lung cancer in Canada: Does it make a difference?. (2018). Shafrin, Jason ; Jansen, Jeroen ; Penrod, John R ; Hertel, Nadine ; Lees, Michael ; Villeneuve, Julie ; Brauer, Michelle ; Skornicki, Michelle. In: Health Policy. RePEc:eee:hepoli:v:122:y:2018:i:6:p:607-613.

Full description at Econpapers || Download paper

2019Physical exercise versus shorter life expectancy? An investigation into preferences for physical activity using a stated preference approach. (2019). Gyrd-Hansen, Dorte ; Hojgaard, Betina ; Kjar, Trine. In: Health Policy. RePEc:eee:hepoli:v:123:y:2019:i:8:p:790-796.

Full description at Econpapers || Download paper

2017The insurance value of medical innovation. (2017). Malani, Anup ; Lakdawalla, Darius ; Reif, Julian . In: Journal of Public Economics. RePEc:eee:pubeco:v:145:y:2017:i:c:p:94-102.

Full description at Econpapers || Download paper

2019Malpractice risk and medical treatment selection. (2019). Grembi, Veronica ; Bertoli, Paola. In: Journal of Public Economics. RePEc:eee:pubeco:v:174:y:2019:i:c:p:22-35.

Full description at Econpapers || Download paper

2017Time and money expenditure in sports participation: The role of income in consuming the most practiced sports activities in Flanders. (2017). Eakins, John ; Vos, Steven ; Scheerder, Jeroen ; Thibaut, Erik . In: Sport Management Review. RePEc:eee:spomar:v:20:y:2017:i:5:p:455-467.

Full description at Econpapers || Download paper

2019The Dozen Things Experimental Economists Should Do (More of). (2019). List, John ; Jimenez-Gomez, David ; Czibor, Eszter. In: Artefactual Field Experiments. RePEc:feb:artefa:00648.

Full description at Econpapers || Download paper

2019Does Medicare Coverage Improve Cancer Detection and Mortality Outcomes?. (2019). Myerson, Rebecca ; Lakdawalla, Darius ; Goldman, Dana ; Tucker-Seeley, Reginald . In: Working Papers. RePEc:hka:wpaper:2019-054.

Full description at Econpapers || Download paper

2017The Economic Burden of Chronic Diseases: Estimates and Projections for China, Japan and South Korea. (2017). Prettner, Klaus ; Oxley, Les ; McGovern, Mark ; Kuhn, Michael ; Bloom, David ; Chen, Simiao . In: IZA Discussion Papers. RePEc:iza:izadps:dp10896.

Full description at Econpapers || Download paper

2018Value Based Pricing of Pharmaceuticals in the US and UK: Does Centralized Cost Effectiveness Analysis Matter?. (2018). Comanor, William S ; Schoenberg, Frederic ; Riddle, Jon M ; Schweitzer, Stuart O. In: Review of Industrial Organization. RePEc:kap:revind:v:52:y:2018:i:4:d:10.1007_s11151-018-9616-1.

Full description at Econpapers || Download paper

2018Measuring the Potential Health Impact of Personalized Medicine: Evidence from Multiple Sclerosis Treatments. (2018). Hult, Kristopher. In: NBER Chapters. RePEc:nbr:nberch:13990.

Full description at Econpapers || Download paper

2017The Economic Burden of Chronic Diseases: Estimates and Projections for China, Japan, and South Korea. (2017). Prettner, Klaus ; Oxley, Les ; McGovern, Mark ; Kuhn, Michael ; Bloom, David ; Chen, Simiao . In: NBER Working Papers. RePEc:nbr:nberwo:23601.

Full description at Econpapers || Download paper

2017Measuring the Potential Health Impact of Personalized Medicine: Evidence from MS Treatments. (2017). Hult, Kristopher. In: NBER Working Papers. RePEc:nbr:nberwo:23900.

Full description at Econpapers || Download paper

2018Defensive Medicine: Evidence from Military Immunity. (2018). Gruber, Jonathan ; Frakes, Michael D. In: NBER Working Papers. RePEc:nbr:nberwo:24846.

Full description at Econpapers || Download paper

2019The Dozen Things Experimental Economists Should Do (More of). (2019). List, John ; Jimenez-Gomez, David ; Czibor, Eszter. In: NBER Working Papers. RePEc:nbr:nberwo:25451.

Full description at Econpapers || Download paper

2019Does Medicare Coverage Improve Cancer Detection and Mortality Outcomes?. (2019). Myerson, Rebecca ; Lakdawalla, Darius ; Goldman, Dana ; Tucker-Seeley, Reginald . In: NBER Working Papers. RePEc:nbr:nberwo:26292.

Full description at Econpapers || Download paper

2018Using health technology assessment to assess the value of new medicines: results of a systematic review and expert consultation across eight European countries. (2018). Angelis, Aris ; Kanavos, Panos ; Lange, Ansgar . In: The European Journal of Health Economics. RePEc:spr:eujhec:v:19:y:2018:i:1:d:10.1007_s10198-017-0871-0.

Full description at Econpapers || Download paper

2019When is it too expensive? Cost-effectiveness thresholds and health care decision-making. (2019). Brouwer, Werner ; Versteegh, Matthijs ; Exel, Job ; Baal, Pieter. In: The European Journal of Health Economics. RePEc:spr:eujhec:v:20:y:2019:i:2:d:10.1007_s10198-018-1000-4.

Full description at Econpapers || Download paper

2017Defining Value: The Need for a Longer, Broader View. (2017). Philipson, Tomas J ; Jena, Anupam B ; Kamal-Bahl, Sachin . In: PharmacoEconomics. RePEc:spr:pharme:v:35:y:2017:i:7:d:10.1007_s40273-017-0503-7.

Full description at Econpapers || Download paper

2018Free-Riding in Pharmaceutical Price Regulation: Theory and Evidence. (2018). Pertile, Paolo ; Gamba, Simona ; Forster, Martin. In: Discussion Papers. RePEc:yor:yorken:18/04.

Full description at Econpapers || Download paper

2017The economic burden of chronic diseases: Estimates and projections for China, Japan, and South Korea. (2017). Prettner, Klaus ; Oxley, Les ; McGovern, Mark ; Kuhn, Michael ; Bloom, David ; Chen, Simiao . In: Hohenheim Discussion Papers in Business, Economics and Social Sciences. RePEc:zbw:hohdps:092017.

Full description at Econpapers || Download paper

Works by Anupam B. Jena:


YearTitleTypeCited
2011The Pragmatists Guide to Comparative Effectiveness Research In: Journal of Economic Perspectives.
[Full Text][Citation analysis]
article14
2011The Pragmatists Guide to Comparative Effectiveness Research.(2011) In: NBER Working Papers.
[Full Text][Citation analysis]
This paper has another version. Agregated cites: 14
paper
2009`Me-Too Innovation in Pharmaceutical Markets In: Forum for Health Economics & Policy.
[Full Text][Citation analysis]
article6
2009Me-Too Innovation in Pharmaceutical Markets.(2009) In: NBER Chapters.
[Citation analysis]
This paper has another version. Agregated cites: 6
chapter
2010The Contributions of Improved Therapy and Earlier Detection to Cancer Survival Gains, 1988-2000 In: Forum for Health Economics & Policy.
[Full Text][Citation analysis]
article3
2006Who Benefits from New Medical Technologies? Estimates of Consumer and Producer Surpluses for HIV/AIDS Drugs In: Forum for Health Economics & Policy.
[Full Text][Citation analysis]
article20
2005Who Benefits from New Medical Technologies? Estimates of Consumer and Producer Surpluses for HIV/AIDS Drugs.(2005) In: NBER Working Papers.
[Full Text][Citation analysis]
This paper has another version. Agregated cites: 20
paper
2008Cost-effectiveness analysis and innovation In: Journal of Health Economics.
[Full Text][Citation analysis]
article20
2010An economic evaluation of the war on cancer In: Journal of Health Economics.
[Full Text][Citation analysis]
article19
2009An Economic Evaluation of the War on Cancer.(2009) In: NBER Working Papers.
[Full Text][Citation analysis]
This paper has another version. Agregated cites: 19
paper
2010The economics of intense exercise In: Journal of Health Economics.
[Full Text][Citation analysis]
article20
2011The impact of comparative effectiveness research on health and health care spending In: Journal of Health Economics.
[Full Text][Citation analysis]
article13
2006Health Care, Technological Change, and Altruistic Consumption Externalities In: NBER Working Papers.
[Full Text][Citation analysis]
paper3
2006Surplus Appropriation from R&D and Health Care Technology Assessment Procedures In: NBER Working Papers.
[Full Text][Citation analysis]
paper7
2008The Value of Life in General Equilibrium In: NBER Working Papers.
[Full Text][Citation analysis]
paper8
2009Endogenous Cost-Effectiveness Analysis in Health Care Technology Adoption In: NBER Working Papers.
[Full Text][Citation analysis]
paper18
2014Does Medical Malpractice Law Improve Health Care Quality? In: NBER Working Papers.
[Full Text][Citation analysis]
paper6
2016Self-insuring against Liability Risk: Evidence from Physician Home Values in States with Unlimited Homestead Exemptions In: NBER Working Papers.
[Full Text][Citation analysis]
paper0
2019Is Great Information Good Enough? Evidence from Physicians as Patients In: NBER Working Papers.
[Full Text][Citation analysis]
paper1
2010Altruism and Innovation in Health Care In: Journal of Law and Economics.
[Full Text][Citation analysis]
article2
2007The institute of medicine report on the FDA: where is the science? In: Health Economics.
[Full Text][Citation analysis]
article0

CitEc is a RePEc service, providing citation data for Economics since 2001. Sponsored by INOMICS. Last updated February, 4 2020. Contact: CitEc Team